Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

April 11, 2018

Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma

  • MS Drug Therapies
    /
Once approved, this product could represent a significant milestone for patients with relapsing-remitting multiple sclerosis Mapi Pharma has completed an…
MS Drug Therapies

April 10, 2018

Lesion accumulation is predictive of long-term cognitive decline in multiple sclerosis.

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
Mult Scler Relat Disord. 2018 Mar 6;21:110-116. doi: 10.1016/j.msard.2018.03.002. [Epub ahead of print] Ouellette R1, Bergendal Å2, Shams S3, Martola J3, Mainero C4, Kristoffersen Wiberg M3, Fredrikson…
MS Research Study and Reports

April 10, 2018

Treatment of seizures for patients with multiple sclerosis

  • Multiple Sclerosis (MS) Symptoms
    /
First published: July 8, 2009. Link to full article: [Cochrane Library] Plain language summary Epileptic seizures occur in a relatively small…
Multiple Sclerosis (MS) Symptoms

April 10, 2018

The Effectiveness and Risks of Cranial Electrical Stimulation for the Treatment of Pain, Depression, Anxiety, PTSD, and Insomnia: A Systematic Review [Internet].

  • Misc. Tips - Non MS Related
    /
Shekelle P, Cook I, Miake-Lye IM, Mak S, Booth MS, Shanman R, Beroes JM. Source Washington (DC): Department of Veterans Affairs (US); 2018 Feb.VA Evidence-based Synthesis…
Misc. Tips - Non MS Related

April 10, 2018

6 Talking Points to Bring Up at Your Next Appointment for MS

  • Additional MS resource sites
    /
  • Misc. MS Related
    /
When you have MS, it’s important to be able to communicate well with the medical professionals who are taking care…
Additional MS resource sites

April 10, 2018

RRMS: What You Need to Know About Switching Medications

  • Multiple Sclerosis
    /
Relapse-remitting multiple sclerosis (RRMS) is the most common form of multiple sclerosis (MS). You may have periods where no symptoms…
Multiple Sclerosis

April 9, 2018

Poor Encoding and Weak Early Consolidation Underlie Memory Acquisition Deficits in Multiple Sclerosis: Retroactive Interference, Processing Speed, or Working Memory?

  • MS Research Study and Reports
    /
Abstract Objective Learning and memory impairments are common in multiple sclerosis (MS) and may be related to difficulty acquiring (encoding…
MS Research Study and Reports

April 9, 2018

New MS Therapy Company, Pipeline, to Focus on Rejuvenating Coating That Projects Nerve Cells

  • Multiple Sclerosis
    /
  • Myelin Repair
    /
A new company called Pipeline Therapeutics will focus on developing next-generation therapies for regenerating the key nerve-protection process that is damaged in multiple…
Multiple Sclerosis

April 9, 2018

Online Meditation Course Seen to Help MS Patients Manage Symptoms in Clinical Trial

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Online training in  meditation based on mindfulness can improve the quality of life for multiple sclerosis (MS) patients while easing depression, anxiety, and…
Alternative therapies and devices for Multiple Sclerosis (MS)

April 9, 2018

Natalizumab May Reduce Disease Progression in Multiple Sclerosis

  • SPMS-PPMS News
    /
  • Tysabri
    /
For patients with secondary progressive multiple sclerosis, natalizumab was not superior to placebo for reducing disability progression, according to results published…
SPMS-PPMS News

Categories

Latest Blog Posts